(rac)-(1R,2S)-5'-methoxy-2-(3-(6-morpholinopyridin-3-yl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one

ID: ALA4590185

PubChem CID: 58486131

Max Phase: Preclinical

Molecular Formula: C27H25N5O3

Molecular Weight: 467.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCOCC5)nc4)n[nH]c3c1)C(=O)N2

Standard InChI:  InChI=1S/C27H25N5O3/c1-34-18-4-6-22-20(13-18)27(26(33)29-22)14-21(27)16-2-5-19-23(12-16)30-31-25(19)17-3-7-24(28-15-17)32-8-10-35-11-9-32/h2-7,12-13,15,21H,8-11,14H2,1H3,(H,29,33)(H,30,31)/t21-,27-/m0/s1

Standard InChI Key:  ZWOUJAABXJJBDH-IDISGSTGSA-N

Molfile:  

 
     RDKit          2D

 35 41  0  0  0  0  0  0  0  0999 V2000
    2.4202   -6.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6244   -6.3932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8383   -7.1886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8717   -6.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3279   -6.1058    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7442   -5.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5547   -5.5764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1153   -4.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8667   -4.1737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0521   -3.9952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4951   -4.6069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6915   -7.5296    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1492   -6.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8450   -6.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9002   -5.0111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1745   -5.3991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6041   -5.4495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5760   -6.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3543   -6.5593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8635   -5.9064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3997   -5.2205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6659   -4.4428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4764   -4.2830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7416   -3.5027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1974   -2.8815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3847   -3.0459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1232   -3.8261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4623   -2.1038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2724   -1.9435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5373   -1.1661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9955   -0.5434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1853   -0.7037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9169   -1.4866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4216   -3.5692    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1730   -2.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  2  4  1  1
  2  7  1  0
  6  5  1  0
  5  4  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  4 12  2  0
  1 13  1  6
 13 14  2  0
 14 18  1  0
 17 15  1  0
 15 16  2  0
 16 13  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 21 22  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 25 28  1  0
 34 35  1  0
  9 34  1  0
M  END

Associated Targets(Human)

PLK4 Tchem Serine/threonine-protein kinase PLK4 (1882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.53Molecular Weight (Monoisotopic): 467.1957AlogP: 3.85#Rotatable Bonds: 4
Polar Surface Area: 92.37Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.38CX Basic pKa: 5.37CX LogP: 3.59CX LogD: 3.59
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.47Np Likeness Score: -0.69

References

1. Li SW, Liu Y, Sampson PB, Patel NK, Forrest BT, Edwards L, Laufer R, Feher M, Ban F, Awrey DE, Hodgson R, Beletskaya I, Mao G, Mason JM, Wei X, Luo X, Kiarash R, Green E, Mak TW, Pan G, Pauls HW..  (2016)  Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacy.,  26  (19): [PMID:27592744] [10.1016/j.bmcl.2016.08.063]

Source